 |
|
 |
 |

Home > Company Index > Drugs > Biotechnology-Medicine > Unimed Pharmaceuticals, Inc.
 |
Unimed Pharmaceuticals, Inc. |
 |
 |
 |
PROFILE |
 |
So long, sweet bong. Unimed Pharmaceutical makes Marinol, an appetite-stimulating and nausea-quelling medicine used for treating HIV/AIDS and cancer patients. It is a synthetic form of tetrahydrocannabinol (THC), the primary intoxicant in marijuana. Marinol is used to treat HIV/AIDS and cancer patients. Other drugs sold by Unimed treat urinary tract infections (Maxaquin) and anemia through use of anabolic steroids (Anadrol-50). The firm also makes AndroGel, one of the first testosterone replacement therapies for men approved by the FDA. The company is a subsidiary of Solvay Pharmaceuticals, the US unit of Belgian chemical firm Solvay.
COMPETITION |
 |
Atlantic Technology Ventures, Inc. (ATLC)
Duramed Pharmaceuticals, Inc. (DRMD)
|
 |
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
1998 Sales (mil.): 15.90
1-Yr. Sales Growth: 78.7%
Employees: 70
Revenue per employee: $227,142.86
KEY PEOPLE |
 |
Robert E. Dudley
CEO
CONTACT INFO |
 |
4 Parkway North, 2nd Fl.
Deerfield, IL 60015
US
Phone: 847-282-5400
Fax: 847-374-8480
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |